Unequal follow-up, not two findings: comment on GLP-1 receptor agonists and ischemic optic neuropathy in patients with type 2 diabetes and obesity

AJO International · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles